O	O	O	0	15	Transcriptional	Transcriptional	B-NP	JJ	O	2	NMOD	O
O	O	O	16	23	control	control	I-NP	NN	O	0	ROOT	O
O	O	O	24	26	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	27	34	steroid	steroid	B-NP	NN	O	3	PMOD	O
O	O	O	34	35	-	-	O	HYPH	O	4	NMOD	O
O	O	O	35	44	regulated	regulate	B-NP	VBN	O	7	NMOD	O
O	O	O	45	54	apoptosis	apoptosis	I-NP	NN	O	5	OBJ	O
O	O	O	55	57	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	58	64	murine	murine	B-NP	JJ	B-cell_type	11	NMOD	B-cell_type
O	O	O	65	72	thymoma	thymoma	I-NP	NN	I-cell_type	11	NMOD	I-cell_type
O	O	O	73	78	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	O	78	79	.	.	O	.	O	2	P	O

O	O	O	81	86	Early	Early	B-NP	JJ	O	2	NMOD	O
O	O	O	87	94	studies	study	I-NP	NNS	O	8	SUB	O
O	O	O	95	97	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	98	104	murine	murine	B-NP	JJ	B-cell_line	7	NMOD	B-cell_line
O	O	O	105	106	T	T	I-NP	NN	I-cell_line	7	NMOD	I-cell_line
O	O	O	107	111	cell	cell	I-NP	NN	I-cell_line	7	NMOD	I-cell_line
O	O	O	112	117	lines	line	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	O	118	127	indicated	indicate	B-VP	VBD	O	0	ROOT	O
O	O	O	128	132	that	that	B-SBAR	IN	O	8	VMOD	O
O	O	O	133	148	transcriptional	transcriptional	B-NP	JJ	O	12	NMOD	O
O	O	O	149	164	transactivation	transactivation	I-NP	NN	O	12	NMOD	O
O	O	O	165	174	functions	function	I-NP	NNS	O	25	SUB	O
O	O	O	175	182	encoded	encode	B-VP	VBN	O	12	NMOD	O
O	O	O	183	185	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	186	189	the	the	B-NP	DT	O	17	NMOD	O
T1,T23	B-Protein,B-Entity	B-Protein,B-Entity	190	204	glucocorticoid	glucocorticoid	I-NP	NN	B-protein	17	NMOD	B-protein
T1,T23	I-Protein,I-Entity	I-Protein,I-Entity	205	213	receptor	receptor	I-NP	NN	I-protein	24	NMOD	I-protein
T23	I-Entity	I-Entity	214	215	(	(	O	(	O	20	DEP	O
T2,T23	B-Protein,I-Entity	B-Protein,I-Entity	215	217	GR	GR	B-NP	NN	B-protein	20	DEP	B-protein
T23	I-Entity	I-Entity	217	218	)	)	O	)	O	17	NMOD	O
T23	I-Entity	I-Entity	219	220	N	N	B-NP	NN	O	24	NMOD	O
T23	I-Entity	I-Entity	220	221	-	-	B-NP	HYPH	O	24	NMOD	O
T23	I-Entity	I-Entity	221	229	terminal	terminal	I-NP	JJ	B-protein	24	NMOD	B-protein
T23	I-Entity	I-Entity	230	236	domain	domain	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	O	237	240	are	be	B-VP	VBP	O	9	SBAR	O
O	O	O	241	249	required	require	I-VP	VBN	O	25	VC	O
O	O	O	250	253	for	for	B-PP	IN	O	26	VMOD	O
O	O	O	254	268	glucocorticoid	glucocorticoid	B-NP	NN	O	31	NMOD	O
O	O	O	268	269	-	-	B-NP	HYPH	O	31	NMOD	O
O	O	O	269	277	mediated	mediate	I-NP	VBN	O	31	NMOD	O
O	O	O	278	287	apoptosis	apoptosis	I-NP	NN	O	27	PMOD	O
O	O	O	287	288	.	.	O	.	O	8	P	O

O	O	O	289	296	However	However	B-ADVP	RB	O	11	VMOD	O
O	O	O	296	297	,	,	O	,	O	11	P	O
O	O	O	298	302	more	more	B-NP	RBR	O	4	AMOD	O
O	O	O	303	309	recent	recent	I-NP	JJ	O	5	NMOD	O
O	O	O	310	317	studies	study	I-NP	NNS	O	11	SUB	O
O	O	O	318	320	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	321	326	human	human	B-NP	JJ	B-cell_line	10	NMOD	B-cell_line
O	O	O	327	328	T	T	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	329	333	cell	cell	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	334	339	lines	line	I-NP	NNS	I-cell_line	6	PMOD	I-cell_line
O	O	O	340	344	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	345	354	suggested	suggest	I-VP	VBN	O	11	VC	O
O	O	O	355	359	that	that	B-SBAR	IN	O	28	DEP	O
O	O	O	360	363	the	the	B-NP	DT	O	18	NMOD	O
T24	B-Entity	B-Entity	364	365	N	N	I-NP	NN	B-protein	18	NMOD	B-protein
T24	I-Entity	I-Entity	365	366	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T24	I-Entity	I-Entity	366	374	terminal	terminal	I-NP	JJ	I-protein	18	NMOD	I-protein
T24	I-Entity	I-Entity	375	381	domain	domain	I-NP	NN	I-protein	19	SUB	I-protein
O	O	O	382	384	is	be	B-VP	VBZ	O	13	SBAR	O
O	O	O	385	388	not	not	O	RB	O	19	VMOD	O
O	O	O	389	398	necessary	necessary	B-ADJP	JJ	O	19	PRD	O
O	O	O	399	402	for	for	B-PP	IN	O	21	AMOD	O
O	O	O	403	410	steroid	steroid	B-NP	NN	O	26	NMOD	O
O	O	O	410	411	-	-	O	HYPH	O	26	NMOD	O
O	O	O	411	420	regulated	regulate	B-NP	VBN	O	26	NMOD	O
O	O	O	421	430	apoptosis	apoptosis	I-NP	NN	O	22	PMOD	O
O	O	O	431	434	and	and	O	CC	O	28	DEP	O
O	O	O	435	439	that	that	B-SBAR	IN	O	12	VMOD	O
T3	B-Protein	B-Protein	440	442	GR	GR	B-NP	NN	B-protein	32	NMOD	B-protein
O	O	O	442	443	-	-	B-VP	HYPH	O	32	NMOD	O
O	O	O	443	451	mediated	mediate	B-NP	VBN	O	32	NMOD	O
O	O	O	452	467	transrepression	transrepression	I-NP	NN	O	33	SUB	O
O	O	O	468	471	may	may	B-VP	MD	O	28	SBAR	O
O	O	O	472	474	be	be	I-VP	VB	O	33	VC	O
O	O	O	475	478	the	the	B-NP	DT	O	38	NMOD	O
O	O	O	479	483	more	more	I-NP	RBR	O	37	AMOD	O
O	O	O	484	492	critical	critical	I-NP	JJ	O	38	NMOD	O
O	O	O	493	502	mechanism	mechanism	I-NP	NN	O	34	PRD	O
O	O	O	502	503	.	.	O	.	O	11	P	O

O	O	O	504	506	To	To	B-VP	TO	O	3	VMOD	O
O	O	O	507	513	better	well	I-VP	RBR	O	3	VMOD	O
O	O	O	514	524	understand	understand	I-VP	VB	O	22	VMOD	O
O	O	O	525	528	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	529	541	contribution	contribution	I-NP	NN	O	3	OBJ	O
O	O	O	542	544	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	545	548	the	the	B-NP	DT	O	13	NMOD	O
T4	B-Protein	B-Protein	549	551	GR	GR	I-NP	NN	B-protein	13	NMOD	B-protein
T25	B-Entity	B-Entity	552	553	N	N	I-NP	NN	I-protein	13	NMOD	I-protein
T25	I-Entity	I-Entity	553	554	-	-	B-NP	HYPH	I-protein	13	P	I-protein
T25	I-Entity	I-Entity	554	562	terminal	terminal	I-NP	JJ	I-protein	13	NMOD	I-protein
T25	I-Entity	I-Entity	563	578	transactivation	transactivation	I-NP	NN	I-protein	13	NMOD	I-protein
T25	I-Entity	I-Entity	579	585	domain	domain	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	586	588	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	589	598	mediating	mediate	B-VP	VBG	O	14	PMOD	O
O	O	O	599	605	murine	murine	B-NP	JJ	O	18	NMOD	O
O	O	O	606	615	thymocyte	thymocyte	I-NP	NN	O	18	NMOD	O
O	O	O	616	625	apoptosis	apoptosis	I-NP	NN	O	15	OBJ	O
O	O	O	625	626	,	,	O	,	O	22	P	O
O	O	O	627	629	we	we	B-NP	PRP	O	22	SUB	O
O	O	O	630	636	stably	stably	B-ADVP	RB	O	22	VMOD	O
O	O	O	637	648	transfected	transfecte	B-VP	VBD	O	0	ROOT	O
T5	B-Protein	B-Protein	649	651	GR	GR	B-NP	NN	B-protein	31	NMOD	B-protein
O	O	O	651	652	,	,	O	,	O	31	P	O
T6	B-Protein	B-Protein	653	655	GR	GR	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	656	664	variants	variant	I-NP	NNS	I-protein	31	NMOD	I-protein
O	O	O	664	665	,	,	O	,	O	31	P	O
O	O	O	666	669	and	and	O	CC	O	31	NMOD	O
O	O	O	670	673	the	the	B-NP	DT	O	31	NMOD	O
T7	B-Protein	B-Protein	674	682	androgen	androgen	I-NP	NN	B-protein	31	NMOD	B-protein
T7	I-Protein	I-Protein	683	691	receptor	receptor	I-NP	NN	I-protein	22	OBJ	I-protein
O	O	O	692	693	(	(	O	(	O	34	DEP	O
T8	B-Protein	B-Protein	693	695	AR	AR	B-NP	NN	B-protein	34	DEP	B-protein
O	O	O	695	696	)	)	O	)	O	31	NMOD	O
O	O	O	697	701	into	into	B-PP	IN	O	31	NMOD	O
O	O	O	702	710	receptor	receptor	B-NP	NN	B-cell_line	42	NMOD	B-cell_line
O	O	O	710	711	-	-	B-NP	HYPH	I-cell_line	42	P	I-cell_line
O	O	O	711	719	negative	negative	I-NP	JJ	I-cell_line	42	NMOD	I-cell_line
O	O	O	720	723	S49	S49	I-NP	NN	I-cell_line	42	NMOD	I-cell_line
O	O	O	724	730	murine	murine	I-NP	JJ	I-cell_line	42	NMOD	I-cell_line
O	O	O	731	738	thymoma	thymoma	I-NP	NN	I-cell_line	42	NMOD	I-cell_line
O	O	O	739	744	cells	cell	I-NP	NNS	I-cell_line	35	PMOD	I-cell_line
O	O	O	744	745	.	.	O	.	O	22	P	O

T9	B-Protein	B-Protein	746	748	GR	GR	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	749	759	expression	expression	I-NP	NN	O	3	NMOD	O
O	O	O	760	766	levels	level	I-NP	NNS	O	4	SUB	O
O	O	O	767	771	were	be	B-VP	VBD	O	42	VMOD	O
O	O	O	772	777	shown	show	I-VP	VBN	O	4	VC	O
O	O	O	778	780	to	to	I-VP	TO	O	7	VMOD	O
O	O	O	781	783	be	be	I-VP	VB	O	5	VMOD	O
O	O	O	784	788	rate	rate	B-NP	NN	O	7	PRD	O
O	O	O	788	789	-	-	O	HYPH	O	8	P	O
O	O	O	789	797	limiting	limit	B-VP	VBG	O	8	NMOD	O
O	O	O	798	801	for	for	B-PP	IN	O	10	VMOD	O
O	O	O	802	812	initiating	initiate	B-VP	VBG	O	11	PMOD	O
O	O	O	813	816	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	817	826	apoptotic	apoptotic	I-NP	JJ	O	15	NMOD	O
O	O	O	827	834	pathway	pathway	I-NP	NN	O	12	OBJ	O
O	O	O	834	835	,	,	O	,	O	42	P	O
O	O	O	836	839	and	and	O	CC	O	42	VMOD	O
O	O	O	840	841	a	a	B-NP	DT	O	20	NMOD	O
O	O	O	842	850	positive	positive	I-NP	JJ	O	20	NMOD	O
O	O	O	851	862	correlation	correlation	I-NP	NN	O	42	SUB	O
O	O	O	863	870	between	between	B-PP	IN	O	20	NMOD	O
O	O	O	871	878	steroid	steroid	B-NP	NN	O	23	NMOD	O
O	O	O	879	890	sensitivity	sensitivity	I-NP	NN	O	28	NMOD	O
O	O	O	891	894	and	and	I-NP	CC	O	28	NMOD	O
T10	B-Protein	B-Protein	895	897	GR	GR	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	897	898	-	-	O	HYPH	O	28	NMOD	O
O	O	O	898	906	mediated	mediate	B-NP	VBN	O	28	NMOD	O
O	O	O	907	916	induction	induction	I-NP	NN	O	21	PMOD	O
O	O	O	917	919	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	920	922	an	an	B-NP	DT	O	41	NMOD	O
O	O	O	923	933	integrated	integrate	I-NP	VBN	O	41	NMOD	O
T26	B-Entity	B-Entity	934	939	mouse	mouse	I-NP	NN	B-DNA	35	NMOD	B-DNA
T26	I-Entity	I-Entity	940	947	mammary	mammary	I-NP	JJ	I-DNA	35	NMOD	I-DNA
T26	I-Entity	I-Entity	948	953	tumor	tumor	I-NP	NN	I-DNA	35	NMOD	I-DNA
T26	I-Entity	I-Entity	954	959	virus	virus	I-NP	NN	I-DNA	41	NMOD	I-DNA
T26	I-Entity	I-Entity	960	961	(	(	O	(	I-DNA	38	DEP	I-DNA
T26	I-Entity	I-Entity	961	965	MMTV	MMTV	B-NP	NN	I-DNA	38	DEP	I-DNA
T26	I-Entity	I-Entity	965	966	)	)	O	)	I-DNA	35	NMOD	I-DNA
T26	I-Entity	I-Entity	967	970	LTR	LTR	B-NP	NN	I-DNA	41	NMOD	I-DNA
T26	I-Entity	I-Entity	971	979	reporter	reporter	I-NP	NN	I-DNA	41	NMOD	I-DNA
T26	I-Entity	I-Entity	980	984	gene	gene	I-NP	NN	I-DNA	29	PMOD	I-DNA
O	O	O	985	988	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	989	997	observed	observe	I-VP	VBN	O	42	VC	O
O	O	O	997	998	.	.	O	.	O	42	P	O

O	O	O	999	1007	Analysis	Analysis	B-NP	NN	O	22	SUB	O
O	O	O	1008	1010	of	of	B-PP	IN	O	1	NMOD	O
T11	B-Protein	B-Protein	1011	1013	GR	GR	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	1014	1022	chimeric	chimeric	I-NP	JJ	I-protein	5	NMOD	I-protein
O	O	O	1023	1032	receptors	receptor	I-NP	NNS	I-protein	2	PMOD	I-protein
O	O	O	1033	1043	containing	contain	B-VP	VBG	O	5	NMOD	O
O	O	O	1044	1047	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	1048	1054	potent	potent	I-NP	JJ	O	14	NMOD	O
T12	B-Protein	B-Protein	1055	1059	VP16	VP16	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	1060	1063	and	and	I-NP	CC	O	8	NMOD	O
T13	B-Protein	B-Protein	1064	1067	E1A	E1A	I-NP	NN	B-protein	8	NMOD	B-protein
T27	B-Entity	B-Entity	1068	1073	viral	viral	I-NP	JJ	O	14	NMOD	O
T27	I-Entity	I-Entity	1074	1089	transactivation	transactivation	I-NP	NN	O	14	NMOD	O
T27	I-Entity	I-Entity	1090	1097	domains	domain	I-NP	NNS	O	6	OBJ	O
O	O	O	1098	1100	in	in	B-PP	IN	O	6	VMOD	O
O	O	O	1101	1106	place	place	B-NP	NN	O	15	PMOD	O
O	O	O	1107	1109	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1110	1113	the	the	B-NP	DT	O	21	NMOD	O
T14	B-Protein	B-Protein	1114	1116	GR	GR	I-NP	NN	B-protein	21	NMOD	B-protein
T28	B-Entity	B-Entity	1117	1118	N	N	I-NP	NN	I-protein	21	NMOD	I-protein
T28	I-Entity	I-Entity	1119	1127	terminus	terminus	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	O	1128	1136	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	O	1137	1141	that	that	B-SBAR	IN	O	22	VMOD	O
O	O	O	1142	1146	even	even	B-NP	RB	O	27	NMOD	O
O	O	O	1147	1150	low	low	I-NP	JJ	O	27	NMOD	O
O	O	O	1151	1156	level	level	I-NP	NN	O	27	NMOD	O
O	O	O	1157	1167	expression	expression	I-NP	NN	O	31	SUB	O
O	O	O	1168	1170	of	of	B-PP	IN	O	27	NMOD	O
O	O	O	1171	1176	these	these	B-NP	DT	O	30	NMOD	O
O	O	O	1177	1186	receptors	receptor	I-NP	NNS	O	28	PMOD	O
O	O	O	1187	1195	resulted	result	B-VP	VBD	O	23	SBAR	O
O	O	O	1196	1198	in	in	B-PP	IN	O	31	VMOD	O
O	O	O	1199	1203	both	both	B-NP	DT	O	39	NMOD	O
O	O	O	1204	1212	enhanced	enhance	B-VP	VBD	O	36	NMOD	O
O	O	O	1213	1220	steroid	steroid	B-NP	NN	O	36	NMOD	O
O	O	O	1221	1232	sensitivity	sensitivity	I-NP	NN	O	39	NMOD	O
O	O	O	1233	1236	and	and	O	CC	O	39	NMOD	O
T29	B-Entity	B-Entity	1237	1241	MMTV	MMTV	B-NP	NN	O	39	NMOD	O
O	O	O	1242	1251	induction	induction	I-NP	NN	O	32	PMOD	O
O	O	O	1251	1252	,	,	O	,	O	31	P	O
O	O	O	1253	1257	thus	thus	B-ADVP	RB	O	42	VMOD	O
O	O	O	1258	1268	supporting	support	B-VP	VBG	O	31	VMOD	O
O	O	O	1269	1270	a	a	B-NP	DT	O	44	NMOD	O
O	O	O	1271	1275	role	role	I-NP	NN	O	42	OBJ	O
O	O	O	1276	1279	for	for	B-PP	IN	O	44	NMOD	O
O	O	O	1280	1295	transactivation	transactivation	B-NP	NN	O	45	PMOD	O
O	O	O	1296	1298	in	in	B-PP	IN	O	46	NMOD	O
O	O	O	1299	1308	apoptosis	apoptosis	B-NP	NN	O	47	PMOD	O
O	O	O	1308	1309	.	.	O	.	O	22	P	O

O	O	O	1310	1312	In	In	B-PP	IN	O	5	VMOD	O
O	O	O	1313	1321	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	1321	1322	,	,	O	,	O	5	P	O
O	O	O	1323	1325	we	we	B-NP	PRP	O	5	SUB	O
O	O	O	1326	1331	found	find	B-VP	VBD	O	0	ROOT	O
O	O	O	1332	1336	that	that	B-SBAR	IN	O	5	VMOD	O
T15	B-Protein	B-Protein	1337	1339	AR	AR	B-NP	NN	B-protein	8	SUB	B-protein
O	O	O	1340	1343	can	can	B-VP	MD	O	6	SBAR	O
O	O	O	1344	1352	initiate	initiate	I-VP	VB	O	8	VC	O
O	O	O	1353	1362	apoptosis	apoptosis	B-NP	NN	O	9	OBJ	O
O	O	O	1363	1365	in	in	B-PP	IN	O	10	NMOD	O
O	O	O	1366	1369	S49	S49	B-NP	NN	B-cell_line	13	NMOD	B-cell_line
O	O	O	1370	1375	cells	cell	I-NP	NNS	I-cell_line	11	PMOD	I-cell_line
O	O	O	1376	1381	after	after	B-PP	IN	O	9	VMOD	O
O	O	O	1382	1391	treatment	treatment	B-NP	NN	O	14	PMOD	O
O	O	O	1392	1396	with	with	B-PP	IN	O	15	NMOD	O
O	O	O	1397	1398	5	5	B-NP	CD	O	19	AMOD	O
O	O	O	1399	1404	alpha	alpha	I-NP	SYM	O	19	AMOD	O
O	O	O	1404	1405	-	-	I-NP	HYPH	O	20	NMOD	O
O	O	O	1405	1424	dihydrotestosterone	dihydrotestosterone	I-NP	NN	O	16	PMOD	O
O	O	O	1424	1425	,	,	O	,	O	9	P	O
O	O	O	1426	1433	despite	despite	B-PP	IN	O	9	VMOD	O
O	O	O	1434	1437	its	its	B-NP	PRP$	O	25	NMOD	O
O	O	O	1438	1446	relative	relative	I-NP	JJ	O	25	NMOD	O
O	O	O	1447	1456	inability	inability	I-NP	NN	O	22	PMOD	O
O	O	O	1457	1459	to	to	B-VP	TO	O	27	VMOD	O
O	O	O	1460	1466	induce	induce	I-VP	VB	O	25	NMOD	O
O	O	O	1467	1471	high	high	B-NP	JJ	O	30	NMOD	O
O	O	O	1472	1477	level	level	I-NP	NN	O	30	NMOD	O
O	O	O	1478	1488	expression	expression	I-NP	NN	O	27	OBJ	O
O	O	O	1489	1491	of	of	B-PP	IN	O	30	NMOD	O
T30	B-Entity	B-Entity	1492	1496	MMTV	MMTV	B-NP	NN	O	31	PMOD	O
O	O	O	1496	1497	.	.	O	.	O	5	P	O

O	O	O	1498	1500	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	1501	1512	investigate	investigate	I-VP	VB	O	7	VMOD	O
O	O	O	1513	1517	this	this	B-ADVP	DT	O	2	OBJ	O
O	O	O	1518	1525	further	further	I-ADVP	RBR	O	2	VMOD	O
O	O	O	1525	1526	,	,	O	,	O	7	P	O
O	O	O	1527	1529	we	we	B-NP	PRP	O	7	SUB	O
O	O	O	1530	1538	examined	examine	B-VP	VBD	O	0	ROOT	O
O	O	O	1539	1542	the	the	B-NP	DT	O	7	VMOD	O
O	O	O	1543	1550	steroid	steroid	I-NP	NN	O	8	DEP	O
O	O	O	1550	1551	-	-	O	HYPH	O	9	P	O
O	O	O	1551	1560	regulated	regulate	B-VP	VBN	O	9	NMOD	O
O	O	O	1561	1571	expression	expression	B-NP	NN	O	11	OBJ	O
O	O	O	1572	1574	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	1575	1577	an	an	B-NP	DT	O	16	NMOD	O
O	O	O	1578	1588	endogenous	endogenous	I-NP	JJ	B-cell_type	16	NMOD	B-cell_type
T31	B-Entity	B-Entity	1589	1598	thymocyte	thymocyte	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
T31	I-Entity	I-Entity	1598	1599	-	-	B-NP	HYPH	O	19	NMOD	O
T31	I-Entity	I-Entity	1599	1607	specific	specific	I-NP	JJ	O	19	NMOD	O
T31	I-Entity	I-Entity	1608	1612	gene	gene	I-NP	NN	O	13	PMOD	O
O	O	O	1613	1619	called	call	B-VP	VBN	O	19	NMOD	O
T16	B-Protein	B-Protein	1620	1625	GIG18	GIG18	B-NP	NN	B-DNA	20	VMOD	B-DNA
O	O	O	1625	1626	.	.	O	.	O	7	P	O

O	O	O	1627	1629	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	1630	1635	found	find	B-VP	VBD	O	0	ROOT	O
O	O	O	1636	1640	that	that	B-SBAR	IN	O	2	VMOD	O
T17	B-Protein	B-Protein	1641	1646	GIG18	GIG18	B-NP	NN	B-DNA	5	SUB	B-DNA
O	O	O	1647	1650	was	be	B-VP	VBD	O	3	SBAR	O
O	O	O	1651	1658	rapidly	rapidly	I-VP	RB	O	5	VMOD	O
O	O	O	1659	1666	induced	induce	I-VP	VBN	O	5	VC	O
O	O	O	1667	1669	to	to	B-PP	TO	O	7	VMOD	O
O	O	O	1670	1680	comparable	comparable	B-NP	JJ	O	10	NMOD	O
O	O	O	1681	1687	levels	level	I-NP	NNS	O	8	PMOD	O
O	O	O	1688	1690	by	by	B-PP	IN	O	7	VMOD	O
O	O	O	1691	1695	both	both	B-NP	CC	O	15	NMOD	O
T18	B-Protein	B-Protein	1696	1698	AR	AR	I-NP	NNS	B-protein	15	NMOD	B-protein
O	O	O	1699	1702	and	and	I-NP	CC	O	15	NMOD	O
T19	B-Protein	B-Protein	1703	1705	GR	GR	I-NP	NN	B-protein	11	PMOD	B-protein
O	O	O	1705	1706	,	,	O	,	O	5	P	O
O	O	O	1707	1720	demonstrating	demonstrate	B-VP	VBG	O	5	VMOD	O
O	O	O	1721	1725	that	that	B-SBAR	IN	O	34	DEP	O
T20	B-Protein	B-Protein	1726	1728	AR	AR	B-NP	NN	B-protein	20	SUB	B-protein
O	O	O	1729	1732	can	can	B-VP	MD	O	18	SBAR	O
O	O	O	1733	1739	indeed	indeed	I-VP	RB	O	20	VMOD	O
O	O	O	1740	1748	function	function	I-VP	VB	O	20	VC	O
O	O	O	1749	1751	as	as	B-PP	IN	O	22	VMOD	O
O	O	O	1752	1753	a	a	B-NP	DT	O	26	NMOD	O
O	O	O	1754	1769	transcriptional	transcriptional	I-NP	JJ	B-protein	26	NMOD	B-protein
O	O	O	1770	1779	activator	activator	I-NP	NN	I-protein	23	PMOD	I-protein
O	O	O	1780	1782	in	in	B-PP	IN	O	26	NMOD	O
O	O	O	1783	1786	S49	S49	B-NP	NN	B-cell_line	29	NMOD	B-cell_line
O	O	O	1787	1792	cells	cell	I-NP	NNS	I-cell_line	27	PMOD	I-cell_line
O	O	O	1793	1796	and	and	O	CC	O	34	DEP	O
O	O	O	1796	1797	,	,	O	,	O	34	P	O
O	O	O	1798	1806	moreover	moreover	B-ADVP	RB	O	34	DEP	O
O	O	O	1806	1807	,	,	O	,	O	34	P	O
O	O	O	1808	1812	that	that	B-SBAR	IN	O	17	VMOD	O
T21	B-Protein	B-Protein	1813	1818	GIG18	GIG18	B-NP	NN	B-DNA	36	NMOD	B-DNA
O	O	O	1819	1828	induction	induction	I-NP	NN	O	37	SUB	O
O	O	O	1829	1832	may	may	B-VP	MD	O	34	SBAR	O
O	O	O	1833	1835	be	be	I-VP	VB	O	37	VC	O
O	O	O	1836	1837	a	a	B-NP	DT	O	40	NMOD	O
O	O	O	1838	1844	marker	marker	I-NP	NN	O	38	PRD	O
O	O	O	1845	1847	of	of	B-PP	IN	O	40	NMOD	O
O	O	O	1848	1853	early	early	B-NP	JJ	O	44	NMOD	O
O	O	O	1854	1863	apoptotic	apoptotic	I-NP	JJ	O	44	NMOD	O
O	O	O	1864	1870	events	event	I-NP	NNS	O	41	PMOD	O
O	O	O	1871	1873	in	in	B-PP	IN	O	44	NMOD	O
O	O	O	1874	1881	steroid	steroid	B-NP	NN	B-cell_line	49	NMOD	B-cell_line
O	O	O	1881	1882	-	-	B-NP	HYPH	I-cell_line	49	NMOD	I-cell_line
O	O	O	1882	1889	treated	treat	I-NP	VBN	I-cell_line	49	NMOD	I-cell_line
O	O	O	1890	1895	cells	cell	I-NP	NNS	I-cell_line	45	PMOD	I-cell_line
O	O	O	1895	1896	.	.	O	.	O	2	P	O

O	O	O	1897	1902	Taken	Take	B-VP	VBN	O	6	VMOD	O
O	O	O	1903	1911	together	together	B-ADVP	RB	O	1	VMOD	O
O	O	O	1911	1912	,	,	O	,	O	6	P	O
O	O	O	1913	1918	these	these	B-NP	DT	O	5	NMOD	O
O	O	O	1919	1926	results	result	I-NP	NNS	O	6	SUB	O
O	O	O	1927	1934	support	support	B-VP	VBP	O	0	ROOT	O
O	O	O	1935	1938	our	our	B-NP	PRP$	O	8	NMOD	O
O	O	O	1939	1949	conclusion	conclusion	I-NP	NN	O	6	OBJ	O
O	O	O	1950	1954	that	that	B-SBAR	IN	O	8	NMOD	O
O	O	O	1955	1970	transcriptional	transcriptional	B-NP	JJ	O	11	NMOD	O
O	O	O	1971	1986	transactivation	transactivation	I-NP	NN	O	12	SUB	O
O	O	O	1987	1989	is	be	B-VP	VBZ	O	9	SBAR	O
O	O	O	1990	1991	a	a	B-NP	DT	O	16	NMOD	O
O	O	O	1992	2001	necessary	necessary	I-NP	JJ	O	16	NMOD	O
O	O	O	2002	2011	signaling	signaling	I-NP	NN	O	16	NMOD	O
O	O	O	2012	2021	component	component	I-NP	NN	O	12	PRD	O
O	O	O	2022	2024	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	2025	2028	S49	S49	B-NP	NN	O	20	NMOD	O
O	O	O	2029	2033	cell	cell	I-NP	NN	O	20	NMOD	O
O	O	O	2034	2043	apoptosis	apoptosis	I-NP	NN	O	17	PMOD	O
O	O	O	2043	2044	,	,	O	,	O	6	P	O
O	O	O	2045	2053	although	although	B-SBAR	IN	O	6	VMOD	O
O	O	O	2054	2056	an	an	B-NP	DT	O	25	NMOD	O
O	O	O	2057	2067	additional	additional	I-NP	JJ	O	25	NMOD	O
O	O	O	2068	2072	role	role	I-NP	NN	O	31	SUB	O
O	O	O	2073	2076	for	for	B-PP	IN	O	25	NMOD	O
T22	B-Protein	B-Protein	2077	2079	GR	GR	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	O	2079	2080	-	-	O	HYPH	O	30	NMOD	O
O	O	O	2080	2088	mediated	mediate	B-NP	VBN	O	30	NMOD	O
O	O	O	2089	2104	transrepression	transrepression	I-NP	NN	O	26	PMOD	O
O	O	O	2105	2111	cannot	cannot	B-VP	MD	O	22	SBAR	O
O	O	O	2112	2114	be	be	I-VP	VB	O	31	VC	O
O	O	O	2115	2123	excluded	exclude	I-VP	VBN	O	32	VC	O
O	O	O	2123	2124	.	.	O	.	O	6	P	O
